These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30595642)

  • 61. Open label aripiprazole in the treatment of youth with tic disorders.
    Murphy TK; Mutch PJ; Reid JM; Edge PJ; Storch EA; Bengtson M; Yang M
    J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):441-7. PubMed ID: 19702496
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of shorter exposure versus prolonged exposure on treatment outcome in Tourette syndrome and chronic tic disorders - an open trial.
    van de Griendt JMTM; van Dijk MK; Verdellen CWJ; Verbraak MJPM
    Int J Psychiatry Clin Pract; 2018 Nov; 22(4):262-267. PubMed ID: 29325470
    [No Abstract]   [Full Text] [Related]  

  • 63. Effects of tic suppression: ability to suppress, rebound, negative reinforcement, and habituation to the premonitory urge.
    Specht MW; Woods DW; Nicotra CM; Kelly LM; Ricketts EJ; Conelea CA; Grados MA; Ostrander RS; Walkup JT
    Behav Res Ther; 2013 Jan; 51(1):24-30. PubMed ID: 23168328
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V; Kim YS; Scahill L
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deep brain stimulation for Tourette syndrome: a single-center series.
    Dowd RS; Pourfar M; Mogilner AY
    J Neurosurg; 2018 Feb; 128(2):596-604. PubMed ID: 28387621
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.
    Wang LJ; Chou WJ; Chou MC; Gau SS
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):442-8. PubMed ID: 27028456
    [TBL] [Abstract][Full Text] [Related]  

  • 68. VOIP for Telerehabilitation: A Risk Analysis for Privacy, Security and HIPAA Compliance: Part II.
    Watzlaf VJ; Moeini S; Matusow L; Firouzan P
    Int J Telerehabil; 2011; 3(1):3-10. PubMed ID: 25945177
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessing Environmental Consequences of Ticcing in Youth with Chronic Tic Disorders: The Tic Accommodation and Reactions Scale.
    Capriotti MR; Piacentini JC; Himle MB; Ricketts EJ; Espil FM; Lee HJ; Turkel JE; Woods DW
    Child Health Care; 2015; 44(3):205-220. PubMed ID: 27076696
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of tic characteristics between children and adults.
    Cubo E; Chmura T; Goetz CG
    Mov Disord; 2008 Dec; 23(16):2407-11. PubMed ID: 18855922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. VoIP for Telerehabilitation: A Pilot Usability Study for HIPAA Compliance.
    Watzlaf VR; Ondich B
    Int J Telerehabil; 2012; 4(1):25-32. PubMed ID: 25945194
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.
    Singer HS; Wendlandt J; Krieger M; Giuliano J
    Neurology; 2001 Mar; 56(5):599-604. PubMed ID: 11245709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tic reduction with pergolide in a randomized controlled trial in children.
    Gilbert DL; Dure L; Sethuraman G; Raab D; Lane J; Sallee FR
    Neurology; 2003 Feb; 60(4):606-11. PubMed ID: 12601100
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Premonitory Awareness Facilitates Tic Suppression: Subscales of the Premonitory Urge for Tics Scale and a New Self-Report Questionnaire for Tic-Associated Sensations.
    Matsuda N; Nonaka M; Kono T; Fujio M; Nobuyoshi M; Kano Y
    Front Psychiatry; 2020; 11():592. PubMed ID: 32719621
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Efficacy of Acupuncture on Tic Disorders in Children: A Retrospective and Propensity Score-Matched Study.
    You HZ; Zhou YF; Yu PB; Xie J; Chen J; Li JJ; Wang GH; Sun KX
    Front Pediatr; 2021; 9():745212. PubMed ID: 34805042
    [No Abstract]   [Full Text] [Related]  

  • 77. Voice over Internet protocol for the orthodontic practice: a sensible switch from plain old telephone service.
    Mupparapu M
    Am J Orthod Dentofacial Orthop; 2008 Mar; 133(3):470-5. PubMed ID: 18331949
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systematic review of severity scales and screening instruments for tics: Critique and recommendations.
    Martino D; Pringsheim TM; Cavanna AE; Colosimo C; Hartmann A; Leckman JF; Luo S; Munchau A; Goetz CG; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2017 Mar; 32(3):467-473. PubMed ID: 28071825
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders.
    Cox JH; Seri S; Cavanna AE
    Pediatric Health Med Ther; 2016; 7():57-64. PubMed ID: 29388585
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study.
    Hoekstra PJ; Minderaa RB; Kallenberg CG
    J Clin Psychiatry; 2004 Apr; 65(4):537-42. PubMed ID: 15119917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.